The Law of Chemical, Metallurgical and Pharmaceutical PatentsHoward I. Forman Central Book Company, 1967 - 863 lappuses |
No grāmatas satura
1.–3. rezultāts no 84.
103. lappuse
... knowledge and use by another in this country of an alleged invention before the patentee's invention thereof in- validates the patent . It does not vitiate the defense that the prior knowledge and use was not publicized or that the use ...
... knowledge and use by another in this country of an alleged invention before the patentee's invention thereof in- validates the patent . It does not vitiate the defense that the prior knowledge and use was not publicized or that the use ...
104. lappuse
... knowledge and use must be accessible to the public . It must also be of substantially the same invention and such knowledge or use must be known at the time the invention is made . The limiting measure of an inventor's rights is ...
... knowledge and use must be accessible to the public . It must also be of substantially the same invention and such knowledge or use must be known at the time the invention is made . The limiting measure of an inventor's rights is ...
202. lappuse
... knowledge , that he is not the first inventor , there is a deception , a fraud , which is practiced in the se- curing of that patent . Where the patentee has personal knowledge of a prior use on the part of another , or prior knowledge ...
... knowledge , that he is not the first inventor , there is a deception , a fraud , which is practiced in the se- curing of that patent . Where the patentee has personal knowledge of a prior use on the part of another , or prior knowledge ...
Saturs
Chapter | 1 |
By CHARLES C PRICE | 15 |
By JOHN T CONNOR AND I LOUIS WOLK | 25 |
Autortiesības | |
15 citas sadaļas nav parādītas.
Bieži izmantoti vārdi un frāzes
2nd Cir affidavit alloy assignment basis Board of Appeals chemical compound chemical patent chromium claims Company considered Corp court held Court of Customs Customs and Patent decision diligence disclosed discovery discussed doctrine of equivalents double patenting drug effect estoppel Examiner example fact filing date granted industry infringement ingredients interference interference proceedings invalid inventor inventorship involved issue license licensor limited machine manufacture Markush material ment method motion obtain obvious party Patent Act Patent Appeals patent application Patent Attorney Patent Examining patent law Patent Office patent system patented invention pharmaceutical present printed publication prior art priority problem proof properties question reason reduction to practice reference reissue rejection result royalty Rule Section 103 situation skilled SOC'Y specification statement statute statutory steel subject matter supra thing tion U.S. Patent United unobvious vention